Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

<p>Raw log2LFQ values for kinases profiled by MIB/MS</p>

Salvato in:

Dettagli Bibliografici
Autore principale:	Alyssa C. Flint (16676029) (author)
Altri autori:	Dana K. Mitchell (16676032) (author), Steven P. Angus (15084264) (author), Abbi E. Smith (16676035) (author), Waylan Bessler (16676038) (author), Li Jiang (16676041) (author), Henry Mang (15293185) (author), Xiaohong Li (16676044) (author), Qingbo Lu (16676047) (author), Brooke Rodriguez (16676050) (author), George E. Sandusky (16676053) (author), Andi R. Masters (16676056) (author), Chi Zhang (15084270) (author), Pengtao Dang (16676059) (author), Jenna Koenig (16676062) (author), Gary L. Johnson (15081520) (author), Weihua Shen (16676065) (author), Jiangang Liu (15018711) (author), Amit Aggarwal (16610489) (author), Gregory P. Donoho (16676068) (author), Melinda D. Willard (16676071) (author), Shripad V. Bhagwat (16676074) (author), D. Wade Clapp (16676077) (author), Steven D. Rhodes (16676080) (author)
Pubblicazione:	2025
Soggetti:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

_version_	1849927632433446912
author	Alyssa C. Flint (16676029)
author2	Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080)
author2_role	author author author author author author author author author author author author author author author author author author author author author author author
author_facet	Alyssa C. Flint (16676029) Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080)
author_role	author
dc.creator.none.fl_str_mv	Alyssa C. Flint (16676029) Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080)
dc.date.none.fl_str_mv	2025-11-25T13:24:28Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30708772
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Table_S2_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708772
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
dc.title.none.fl_str_mv	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Raw log2LFQ values for kinases profiled by MIB/MS</p>
eu_rights_str_mv	openAccess
id	Manara_cb5cc4a08541c35588180abe50bcb1ec
identifier_str_mv	10.1158/1078-0432.30708772
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30708772
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C. Flint (16676029)Dana K. Mitchell (16676032)Steven P. Angus (15084264)Abbi E. Smith (16676035)Waylan Bessler (16676038)Li Jiang (16676041)Henry Mang (15293185)Xiaohong Li (16676044)Qingbo Lu (16676047)Brooke Rodriguez (16676050)George E. Sandusky (16676053)Andi R. Masters (16676056)Chi Zhang (15084270)Pengtao Dang (16676059)Jenna Koenig (16676062)Gary L. Johnson (15081520)Weihua Shen (16676065)Jiangang Liu (15018711)Amit Aggarwal (16610489)Gregory P. Donoho (16676068)Melinda D. Willard (16676071)Shripad V. Bhagwat (16676074)D. Wade Clapp (16676077)Steven D. Rhodes (16676080)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyCell CycleCDKs and CDK inhibitorsChemotherapyCombination chemotherapyGene TechnologiesHigh-throughput sequencingPreclinical ModelsAnimal models of cancerProteomicsRare CancersTranslational Research<p>Raw log2LFQ values for kinases profiled by MIB/MS</p>2025-11-25T13:24:28ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708772https://figshare.com/articles/dataset/Table_S2_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708772CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307087722025-11-25T13:24:28Z
spellingShingle	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma Alyssa C. Flint (16676029) Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research
status_str	publishedVersion
title	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_full	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_fullStr	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_full_unstemmed	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_short	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
title_sort	Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
topic	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Documenti analoghi